Medication Use Evaluation of Dronedarone in Comparison to Amiodarone
Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...
主要な著者: | Adam Corey, Nita Johnston |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
University of Minnesota Libraries Publishing
2016-12-01
|
シリーズ: | INNOVATIONS in Pharmacy |
主題: | |
オンライン・アクセス: | https://pubs.lib.umn.edu/index.php/innovations/article/view/480 |
類似資料
-
Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
著者:: Li Y, 等
出版事項: (2023-12-01) -
Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
著者:: Mengran Zhang, 等
出版事項: (2021-08-01) -
Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
著者:: Li-Qin Jiang, 等
出版事項: (2016-05-01) -
Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
著者:: Trigo P, 等
出版事項: (2011-12-01) -
Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
著者:: M. Yu. Gilyarov, 等
出版事項: (2010-12-01)